REDX:LSE Redx Pharma Plc

GBX 18.50 -0.25 -1.333333
Icon

Redx Pharma Plc (REDX:LSE) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | LSE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 18.50

-0.25 (-1.33)%

GBX 0.07B

0.06M

N/A

N/A

Icon

REDX:LSE

Redx Pharma Plc (GBX)
COMMON STOCK | LSE
GBX 18.50
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 0.07B

N/A

GBX 18.50

Redx Pharma Plc (REDX:LSE) Stock Forecast

N/A

Based on the Redx Pharma Plc stock forecast from 0 analysts, the average analyst target price for Redx Pharma Plc is not available over the next 12 months. Redx Pharma Plc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Redx Pharma Plc is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Redx Pharma Plc’s stock price was GBX 18.50. Redx Pharma Plc’s stock price has changed by -9.76% over the past week, +0.00% over the past month and -40.32% over the last year.

No recent analyst target price found for Redx Pharma Plc
No recent average analyst rating found for Redx Pharma Plc

Company Overview Redx Pharma Plc

Redx Pharma Plc engages in drug discovery, pre-clinical development, and licensing activities in the United Kingdom. It discovers and develops small molecule drugs for treating fibrotic disease, cancer, and the emerging area of cancer-associated fibrosis in the areas of unmet med...Read More

https://www.redxpharma.com

Alderley Park, Macclesfield, United Kingdom, SK10 4TG

101

September

GBX

UK

Adjusted Closing Price for Redx Pharma Plc (REDX:LSE)

Loading...

Unadjusted Closing Price for Redx Pharma Plc (REDX:LSE)

Loading...

Share Trading Volume for Redx Pharma Plc Shares

Loading...

Compare Performance of Redx Pharma Plc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for REDX:LSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Redx Pharma Plc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
GNS:LSE
Genus PLC -22.00 (-1.23%) GBX1.30B 38.41 14.99

ETFs Containing REDX

Symbol Name REDX's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Redx Pharma Plc (REDX:LSE) Stock

Stock Target Advisor's fundamental analysis for Redx Pharma Plc's stock is Slightly Bearish.

Unfortunately we do not have enough data on REDX:LSE's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on REDX:LSE's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on REDX:LSE's stock to indicate if its overvalued.

The last closing price of REDX:LSE's stock was GBX 18.50.

The most recent market capitalization for REDX:LSE is GBX 0.07B.

Unfortunately we do not have enough analyst data on REDX:LSE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Redx Pharma Plc's stock.

As per our most recent records Redx Pharma Plc has 101 Employees.

Redx Pharma Plc's registered address is Alderley Park, Macclesfield, United Kingdom, SK10 4TG. You can get more information about it from Redx Pharma Plc's website at https://www.redxpharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...